AI, HTA, and the future of access: Inside the 12th annual Kraków HTA symposium
Explore key insights from the 12th Annual Kraków HTA Symposium covering HTA, reimbursement policy, AI…
Malwina Holownia, PhD2026 年 7 月 8 日
Dosimetry for radiopharmaceutical therapy: From measurement to dose justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhD2026 年 7 月 7 日
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors
The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors
Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…
Certara2026 年 7 月 1 日
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
Alekhya Lavu, PhD, PharmD2026 年 6 月 26 日
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…
Danielle Pillsbury2026 年 6 月 23 日
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling
Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…
Certara2026 年 6 月 22 日
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…
Certara2026 年 6 月 22 日
Machine Learning based drug renal clearance predictor development and application
A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…
Certara2026 年 6 月 22 日
